Go back to Research Experience View external

Breast Cancer Vaccines and Combination Immunotherapy: Current Evidence, Limitations and Future Directions

September 2026 Sodiq, T. A., Lawal, A. O., Adigun , M. A. A., & Shuaibu , A. B. Nigerian Journal of Pharmaceutical and Applied Science Research, 15(3), 35–48.
#Breast Cancer #Cancer Immunotherapy #Cancer Vaccine

I'm pleased to share our scoping review, "Breast Cancer Vaccines and Combination Immunotherapy: Current Evidence, Limitations and Future Directions"

Following PRISMA-ScR methodology, the review maps the current evidence on breast cancer vaccines and combination immunotherapy strategies, examines their limitations, and outlines future directions for research and clinical translation, including in triple-negative breast cancer.

[Read the paper] (https://www.nijophasr.net/index.php/nijophasr/article/view/672)